Format

Send to

Choose Destination
Arch Gen Psychiatry. 2005 Dec;62(12):1313-20.

Cost-effectiveness of improving primary care treatment of late-life depression.

Author information

1
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, 1959 Pacific Street, Seattle, WA 98195, USA. wkaton@u.washington.edu

Abstract

CONTEXT:

Depression is a leading cause of functional impairment in elderly individuals and is associated with high medical costs, but there are large gaps in quality of treatment in primary care.

OBJECTIVE:

To determine the incremental cost-effectiveness of the Improving Mood Promoting Access to Collaborative Treatment (IMPACT) collaborative care management program for late-life depression.

DESIGN:

Randomized controlled trial with recruitment from July 1999 to August 2001.

SETTING:

Eighteen primary care clinics from 8 health care organizations in 5 states.

PARTICIPANTS:

A total of 1801 patients 60 years or older with major depression (17%), dysthymic disorder (30%), or both (53%).

INTERVENTION:

Patients were randomly assigned to the IMPACT intervention (n = 906) or to usual primary care (n = 895). Intervention patients were provided access to a depression care manager supervised by a psychiatrist and primary care physician. Depression care managers offered education, support of antidepressant medications prescribed in primary care, and problem-solving treatment in primary care (a brief psychotherapy).

MAIN OUTCOME MEASURES:

Total outpatient costs, depression-free days, and quality-adjusted life-years.

RESULTS:

Relative to usual care, intervention patients experienced 107 (95% confidence interval [CI], 86 to 128) more depression-free days over 24 months. Total outpatient costs were USD $295 (95% CI, -$525 to $1115) higher during this period. The incremental outpatient cost per depression-free day was USD $2.76 (95% CI, -$4.95 to $10.47) and incremental outpatient costs per quality-adjusted life-year ranged from USD $2519 (95% CI, -$4517 to $9554) to USD $5037 (95% CI, -$9034 to $19 108). Results of a bootstrap analysis suggested a 25% probability that the IMPACT intervention was "dominant" (ie, lower costs and greater effectiveness).

CONCLUSIONS:

The IMPACT intervention is a high-value investment for older adults; it is associated with high clinical benefits at a low increment in health care costs.

PMID:
16330719
DOI:
10.1001/archpsyc.62.12.1313
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center